Leica Microsystems’ latest innovation for cancer research
Cell DIVE, Leica Microsystems’ latest innovation for cancer research, is an open multiplexing system that enables visualization of 60+ biomarkers from one tissue sample at the single-cell level. The solution consists of a comprehensive list of rigorously validated antibodies, fully customizable assay design, tissue-preserving dye inactivation protocol, and a precision engineered imager with intuitive, scalable acquisition and analysis software.
Brands: Cell DIVE